Expression of the hMICL in acute myeloid leukemia: a highly reliable disease marker at diagnosis and during follow-up

Hanne Ø Larsen, Anne S Roug, Tom Just, Gordon D Brown, Peter Hokland

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Stable flow cytometric markers for malignant myeloid cells are highly warranted. Based on data from stem cell research, we hypothesized that the human inhibitory C-type lectin like receptor (hMICL) might represent a novel diagnostic and prognostic vehicle in a standard flow cytometry (FCM) setting.
Original languageEnglish
Pages (from-to)3-8
Number of pages6
JournalCytometry Part B: Clinical Cytometry
Volume82B
Issue number1
Early online date30 Aug 2011
DOIs
Publication statusPublished - Jan 2012

Keywords

  • AML
  • hMICL
  • immunophenotyping
  • LAIP
  • MRD

Fingerprint Dive into the research topics of 'Expression of the hMICL in acute myeloid leukemia: a highly reliable disease marker at diagnosis and during follow-up'. Together they form a unique fingerprint.

Cite this